Company profile
Cogent Biosciences, Inc. insider acquisitions
Company CIK 0001622229 · Reported insider acquisitions and filing context.
These are company listings. A transaction is linked to a particular security only when the filing provides enough information.
Company activity summary
By transaction date, as of October 23, 2026.
| Type / code | Reported security | Transactions | Known purchase value | Missing amounts |
|---|---|---|---|---|
| Stock awardCode A | Stock Option (Right to Buy)Derivative · Currency not specified | 1 | Not applicable | 0 |
Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
20 dated transactions · 7 of 7 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Oct 1, 2026 | Cogent Biosciences, Inc.Stock Option (Right to Buy) | Ferrante Karen Jean | Stock award |
| Jan 1, 2026 | Cogent Biosciences, Inc.Stock Option (Right to Buy) | Ferrante Karen Jean | Stock award |
| Dec 17, 2025 | Cogent Biosciences, Inc.Stock Option (Right to Buy) | Robinson John Edward | Stock award |
| Dec 17, 2025 | Cogent Biosciences, Inc.Common Stock | Robinson John Edward | Stock award |
| Dec 17, 2025 | Cogent Biosciences, Inc.Common Stock | Robinson John Edward | Stock award |
| Dec 17, 2025 | Cogent Biosciences, Inc.Stock Option (Right to Buy) | Robbins Andrew R | Stock award |
| Dec 17, 2025 | Cogent Biosciences, Inc.Common Stock | Robbins Andrew R | Stock award |
| Dec 17, 2025 | Cogent Biosciences, Inc.Common Stock | Robbins Andrew R | Stock award |
| Dec 17, 2025 | Cogent Biosciences, Inc.Stock Option (Right to Buy) | Pinnow Cole | Stock award |
| Dec 17, 2025 | Cogent Biosciences, Inc.Common Stock | Pinnow Cole | Stock award |
| Dec 17, 2025 | Cogent Biosciences, Inc.Common Stock | Pinnow Cole | Stock award |
| Dec 17, 2025 | Cogent Biosciences, Inc.Stock Option (Right to Buy) | Sachs Jessica | Stock award |
| Dec 17, 2025 | Cogent Biosciences, Inc.Common Stock | Sachs Jessica | Stock award |
| Dec 17, 2025 | Cogent Biosciences, Inc.Common Stock | Sachs Jessica | Stock award |
| Dec 17, 2025 | Cogent Biosciences, Inc.Stock Option (Right to Buy) | Kearns Evan | Stock award |
| Dec 17, 2025 | Cogent Biosciences, Inc.Common Stock | Kearns Evan | Stock award |
| Dec 17, 2025 | Cogent Biosciences, Inc.Common Stock | Kearns Evan | Stock award |
| Dec 17, 2025 | Cogent Biosciences, Inc.Stock Option (Right to Buy) | Green John L. | Stock award |
| Dec 17, 2025 | Cogent Biosciences, Inc.Common Stock | Green John L. | Stock award |
| Dec 17, 2025 | Cogent Biosciences, Inc.Common Stock | Green John L. | Stock award |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Share price & reported acquisitions
Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.
Price history is not available
Market-price history is not connected yet.
COGT · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.
Reported acquisitions
Filing-date filters apply to the list and timeline. The summary above uses transaction dates.
| Filed / transacted | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|
| Trade: | Ferrante Karen JeanDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 759 | 0 *Value: 0Currency not specified | View ↗ |
| Trade: | Ferrante Karen JeanDirector | Stock awardStock Option (Right to Buy)Derivative security · Code A | 643 | 0 *Value: 0Currency not specified | View ↗ |
| Trade: | Robinson John EdwardChief Scientific Officer | Stock awardStock Option (Right to Buy)Derivative security · Code A | 65,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Robinson John EdwardChief Scientific Officer | Stock awardCommon StockNon-derivative security · Code A | 320,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Robinson John EdwardChief Scientific Officer | Stock awardCommon StockNon-derivative security · Code A | 50,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Robbins Andrew RPresident and CEO · Director | Stock awardStock Option (Right to Buy)Derivative security · Code A | 245,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Robbins Andrew RPresident and CEO · Director | Stock awardCommon StockNon-derivative security · Code A | 840,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Robbins Andrew RPresident and CEO · Director | Stock awardCommon StockNon-derivative security · Code A | 185,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Pinnow ColeChief Commercial Officer | Stock awardStock Option (Right to Buy)Derivative security · Code A | 65,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Pinnow ColeChief Commercial Officer | Stock awardCommon StockNon-derivative security · Code A | 214,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Pinnow ColeChief Commercial Officer | Stock awardCommon StockNon-derivative security · Code A | 50,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Sachs JessicaChief Medical Officer | Stock awardStock Option (Right to Buy)Derivative security · Code A | 65,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Sachs JessicaChief Medical Officer | Stock awardCommon StockNon-derivative security · Code A | 320,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Sachs JessicaChief Medical Officer | Stock awardCommon StockNon-derivative security · Code A | 50,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Kearns EvanChief Legal Officer | Stock awardStock Option (Right to Buy)Derivative security · Code A | 55,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Kearns EvanChief Legal Officer | Stock awardCommon StockNon-derivative security · Code A | 260,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Kearns EvanChief Legal Officer | Stock awardCommon StockNon-derivative security · Code A | 40,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Green John L.Chief Financial Officer | Stock awardStock Option (Right to Buy)Derivative security · Code A | 65,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Green John L.Chief Financial Officer | Stock awardCommon StockNon-derivative security · Code A | 300,000 | 0Value: 0Currency not specified | View ↗ |
| Trade: | Green John L.Chief Financial Officer | Stock awardCommon StockNon-derivative security · Code A | 50,000 | 0Value: 0Currency not specified | View ↗ |
20 transactions on this page. Filing date, newest first.
Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →